Fortress Biotech, Inc.
FBIO
$2.31
$0.093.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.94M | 5.85M | 15.49M | -10.58M | -6.77M |
| Total Depreciation and Amortization | 1.16M | 1.16M | 1.16M | 1.19M | 1.13M |
| Total Amortization of Deferred Charges | 339.00K | 319.00K | 451.00K | 295.00K | 300.00K |
| Total Other Non-Cash Items | 702.00K | -8.90M | -37.88M | -7.49M | -1.83M |
| Change in Net Operating Assets | -10.81M | -4.53M | -6.78M | -2.98M | -5.73M |
| Cash from Operations | -12.54M | -6.11M | -27.56M | -19.56M | -12.91M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 1.17M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 2.87M | 6.09M | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -15.00M |
| Cash from Investing | 0.00 | 2.87M | 6.09M | 1.17M | -15.00M |
| Total Debt Issued | -- | -- | -- | -- | 5.00M |
| Total Debt Repaid | 55.00K | -130.00K | 0.00 | -625.00K | -625.00K |
| Issuance of Common Stock | 412.00K | 1.80M | 618.00K | 1.13M | 674.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 0.00 | 0.00 | -115.00K | -150.00K | -- |
| Total Dividends Paid | -- | -- | -- | -- | 0.00 |
| Other Financing Activities | 5.24M | 13.40M | 4.02M | 51.79M | 20.76M |
| Cash from Financing | 5.71M | 15.07M | 4.52M | 52.14M | 25.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.84M | 11.83M | -16.95M | 33.74M | -2.10M |